Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02464696

Recruiting

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

for
Cancer, Cancer Pain, Virtual Reality
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT06248216

Recruiting

Cancer and Mild Cognitive Impairment Dyadic Intervention

for
Cancer, Cognitive Impairment
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 70+

Code: NCT05144516

Recruiting

Communication Issues in Patient and Provider Discussions of Immunotherapy

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Decatur GA, Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT05873608

Recruiting

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

for
Metastatic Cancer
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06389123

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Weighted Blanket Use to Reduce Anxiety in Oncology Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06089408

Recruiting

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

for
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer,
Location: Philadelphia PA, Memphis TN, Houston TX, Seattle WA,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 2 - 70+

Code: NCT05783323

Phase 2, Recruiting

Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05411523

Recruiting

The Psychological, Social, and Economic Impacts of COVID-19

for
COVID-19, Chronic Disease, Psychiatric Disorder,
Location: Ottawa
Sponsor: University of Ottawa

Sex: All

Age: 12+

Code: NCT04369690

Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase 1, Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase 1, Phase 2, Recruiting

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

for
Neoplasms, Chemotherapy-induced Nausea and Vomiting
Location: Miami FL, Orlando FL
Sponsor: University of Central Florida

Sex: All

Age: 60+

Code: NCT05838638

Recruiting

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

for
Advanced/Metastatic Solid Tumors
Location: Cleveland OH, Houston TX, Scottsdale AZ, Seattle WA,
Sponsor: Adagene Inc

Sex: All

Age: 18+

Code: NCT05405595

Phase 1, Phase 2, Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer,
Location: Fairfax VA, Durham NC, Charlotte NC, Canton OH,
Sponsor: Sairopa B.V.

Sex: All

Age: 18+

Code: NCT05856981

Phase 1, Recruiting

Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care

for
Cancer, Heart Failure, Copd, ALS
Location: Winnipeg
Sponsor: Riverview Health Centre

Sex: All

Age: 0+

Code: NCT04138095

Recruiting

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

for
Granulocyte Colony-Stimulating Factor,
Location: Jackson MS
Sponsor: University of Mississippi Medical Center

Sex: All

Age: 0 - 21

Code: NCT03823950

Recruiting

Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity

for
Nervous System Disease, Immune System Disease
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 2 - 70+

Code: NCT06169150

Recruiting

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

for
Metastatic Cancers, Fatigue
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06085716

Phase 2, Phase 3, Recruiting

Molecular Analysis Of Solid Tumors

for
Pediatric Solid Tumors
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 25

Code: NCT01050296

Recruiting

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

for
Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18 - 70+

Code: NCT05346796

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial